Dear Reader,

As we approach the end of 2015, and publish our final issue of Drugs & Therapy Perspectives for the year, the editors and production staff at Adis wish to reflect on another successful year’s achievements and pay thanks to all those who have contributed their time and effort to guarantee the exceptional quality of our content.

We are delighted to have seen the conclusion of formalities surrounding the joint venture of Springer Science+Business Media and Nature Publishing Group, Palgrave Macmillan, Macmillan Education in early May. Substantial ground has already been made in the integration of business within the resulting Springer Nature company and we at Adis look eagerly toward the future, as the benefits of the collective expertise and capabilities of this company carry us forward.

The majority of our journals saw a rise in ISI impact factor against the previous year. Most notably, BioDrugs increased by 41 % to 2.989; the European Journal of Drug Metabolism and Pharmacokinetics increased 19 % to 1.563; CNS Drugs increased by 17 % to 5.113; Targeted Oncology increased 16 % to 4.000; Pediatric Drugs increased 15 % to 1.975; Drugs & Aging increased 13 % to 2.838; and Molecular Diagnosis & Therapy increased a further 12 % to 2.891, having already jumped 53 % in the preceding year. We hope to build upon these gains, once more, in 2016.

The Adis Book programme has grown substantially and 20 new titles will have been published over the course of the year. Over 50 further titles are currently in development with leading academics, internationally, and we continue to add more to the list. Our thanks, again, to all who have submitted these valuable proposals to date.

We offer our sincere thanks to all individuals who have reviewed or contributed articles to Drugs & Therapy Perspectives over the course of 2015. Their skill and dedication are critical to the continued publication of the journal and high standard of articles. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals who acted as reviewers for articles published in print in Drugs & Therapy Perspectives in 2015:

Darrell R. Abernethy, USA

N. Agarwal, USA

Luis Almeida, Portugal

Sabina A. Antoniu, Romania

Francisco Araujo, Spain

Mohamed Baraka, Saudi Arabia

Aygin Bayrakta-Ekincioglu, Turkey

Frederic Becq, France

R. H. Belmaker, Israel

Claudia Bernardini, Italy

Yuly Bersudsky, Israel

Chris Theo Bervoets, Belgium

Elvira Bisbe, Spain

Bernd Bokemeyer, Germany

P. Sherwood Burge, UK

David M. Burger, The Netherlands

Margarida Castel-Branco, Portugal

Natalie Cebotarenco, Moldova

Philippe Chanson, France

Barbara Claus, Belgium

Patricia K. Coyle, USA

Philippe P. Devillier, France

Jatin Dhanani, India

Ramkumar Dikshit, India

Pere Domingo, Spain

Suzanne Dunne, Ireland

Anthony Dominic D’Urzo, Canada

Mikael Eriksson, Sweden

Isabel Vitoria Figueiredo, Portugal

Mark Steven Freedman, Canada

Bharat Gajjar, India

Arthur F. Gelb, USA

David Granlund, Sweden

Lars Hagmeyer, Germany

Martina Hahn, Germany

Maria Teresa Ferreira Herdeiro, Portugal

Robert Hermann, Germany

F. Horak, Austria

R. Iacovelli, Italy

Cristoforo Incorvaia, Italy

Rob Janknegt, The Netherlands

Elmar A. Joura, Austria

Gail Judd, Canada

Siegfried Kasper, Austria

Ben Z. Katz, USA

Edward M. Kerwin, USA

Hannelore Kreckel, Germany

Michel Le Duff, France

José Lopes, Portugal

Franco Maggiolo, Italy

Marcio C. Mancini, Brazil

Sanja Mirkov, New Zealand

Joaquim Mullol, Spain

Michael T. Nurmohamed, The Netherlands

Emina Obarcanin, Bosnia and Herzegovina

Ioana Olaru, Germany

Sofia Oliveira-Martins, Portugal

Jigar Panchal, India

Tejas Patel, India

Jose Pérez-Castrillón, Spain

Marek Petras, Czech Republic

Wolfgang Raber, Austria

Isabel Maria Pires Sebastião Ramalhinho, Portugal

Dermot Ryan, UK

Helio S. Sader, USA

Ali Saklamaz, Turkey

Sandeep Saluja, India

Nathan Sandbo, USA

Amit M. Shah, India

Rima Bharatbhai Shah, India

Alpana P. Shukla, USA

Guenther G. Steger, Austria

Maysa Suyagh, Jordan

Carla Teixeira de Barros, Portugal

Paul M. Tulkens, Belgium

Themistoklis Tzotzas, Greece

Willy Marcos Valencia, USA

Jan van Lunzen, Germany

Kirsten K. Viktil, Norway

N. Von Hentig, Germany

Ulrich Wahn, Germany

Mark A. Wainberg, Canada

Jean-Pierre Zellweger, Switzerland

We hope that you have found the articles published throughout 2015 to be both interesting and informative. The editors look forward to keeping you up to date with topical issues related to rational drug use and disease management in the clinical practice setting in 2016.

With best wishes from the staff of Drugs & Therapy Perspectives and all at Adis Publications.